生物信息学分析以确定与乳腺癌相关的潜在标和候选小分子药物
Huan Hong1, Haifeng Chen2, Junjie Zhao2
1Department of Oncology, Jincheng People's Hospital, Jincheng, Shanxi 048026, China.
Mutation research
|July 12, 2023
概括
这项研究确定了乳腺癌中的关键基因,并预测Fostamatinib作为一种潜在的药物. 福斯塔马提尼布通过调节细胞循环,有效地抑制乳腺癌细胞的增殖.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌仍然是全球癌症相关死亡的主要原因.
- 识别新的治疗点和有效的小分子药物对于改善患者的治疗结果至关重要.
- 生物信息学方法为癌症研究中的目标识别和药物查提供了强大的工具.
研究的目的:
- 通过生物信息学分析,识别乳腺癌的潜在治疗点.
- 为选可能针对已识别的乳腺癌基因的小分子药物.
- 在临床前乳腺癌模型中验证预测药物的疗效.
主要方法:
- 对乳腺癌数据集进行了差异基因表达分析 (GSE42568,GSE205185).
- 进行了功能丰富,蛋白与蛋白相互作用 (PPI) 网络和向药物相互作用网络分析.
- 实验室试验 (CCK8,殖民地形成,流细胞计,西斑) 用于评估药物对乳腺癌细胞的影响.
主要成果:
- 十个关键基因 (例如,AURKA,MELK,CDK1,NEK2) 被确定为乳腺癌途径的核心节点.
- 福斯塔马提尼布被预测为一种潜在的药物,针对AURKA,MELK,CDK1和NEK2.
- 福斯塔马提尼布在体外抑制了乳腺癌细胞的增殖,诱导了G2/M阶段的停止,并降低了MELK,AURKA和NEK2蛋白的调节.
结论:
- 福斯塔马提尼布显示出作为乳腺癌治疗剂的巨大潜力.
- 药物的有效性与其调节细胞循环和抑制癌细胞增殖的能力有关.
- 这项研究强调了生物信息学在发现新型癌症药物候选药物的有用性.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
02:26Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
01:26Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K